Biden

US government signs contract with Eli Lilly to supply drug to treat COVID-19

Eli Lilly CEO explains the supply chain of Covid-19 antibody drug

US government signs contract with Eli Lilly to supply drug to treat COVID-19

Government to purchase 300,000 doses of an experimental drug drug

The US government awarded a $ 375 million contract with pharmaceutical company Eli Lilly to supply 300,000 doses of an experimental drug for the treatment of COVID-19, which received positive reviews from President Donald Trump.

The company said it will begin supplying the drug within two months of receiving an emergency use authorization from the U.S. regulatory agency..

The U.S. government is also eligible to purchase up to $ 812.5 million worth of up to 650,000 vials, the Department of Health and Human Services said in a statement..

While vaccines are considered critical to ending the pandemic, governments are increasingly looking for effective treatment options to slow the spread and stimulate economic activity..

Earlier this month, Lilly filed a request with the Food and Drug Administration to get approval for the drug to treat mild to moderate coronavirus patients..

The U.S. government promises that patients will not have to pay for the drug themselves, although healthcare providers may charge a fee for treatment using the drug, Lilly said..

A similar antibody-based drug developed by Regeneron Pharmaceuticals was given to President Trump when he contracted coronavirus.

These medicines belong to a class of medicines called monoclonal antibodies. They are copies of antibodies made by the body to fight infection.US government signs contract with Eli Lilly to supply drug to treat COVID-19 Lilly’s drug uses antibodies detected in a blood sample taken from one of the first patients in the United States to recover from COVID-19.

Similar articles